These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29720407)

  • 1. Diagnostic potential of stored dried blood spots for inborn errors of metabolism: a metabolic autopsy of medium-chain acyl-CoA dehydrogenase deficiency.
    Kaku N; Ihara K; Hirata Y; Yamada K; Lee S; Kanemasa H; Motomura Y; Baba H; Tanaka T; Sakai Y; Maehara Y; Ohga S
    J Clin Pathol; 2018 Oct; 71(10):885-889. PubMed ID: 29720407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency.
    McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L
    Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
    Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
    Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.
    Horvath GA; Davidson AG; Stockler-Ipsiroglu SG; Lillquist YP; Waters PJ; Olpin S; Andresen BS; Palaty J; Nelson J; Vallance H
    Can J Public Health; 2008; 99(4):276-80. PubMed ID: 18767270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.
    Van Hove JL; Zhang W; Kahler SG; Roe CR; Chen YT; Terada N; Chace DH; Iafolla AK; Ding JH; Millington DS
    Am J Hum Genet; 1993 May; 52(5):958-66. PubMed ID: 8488845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands.
    Jager EA; Kuijpers MM; Bosch AM; Mulder MF; Gozalbo ER; Visser G; de Vries M; Williams M; Waterham HR; van Spronsen FJ; Schielen PCJI; Derks TGJ
    J Inherit Metab Dis; 2019 Sep; 42(5):890-897. PubMed ID: 31012112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden unexpected infant death (SUDI) in a newborn due to medium chain acyl CoA dehydrogenase (MCAD) deficiency with an unusual severe genotype.
    Lovera C; Porta F; Caciotti A; Catarzi S; Cassanello M; Caruso U; Gallina MR; Morrone A; Spada M
    Ital J Pediatr; 2012 Oct; 38():59. PubMed ID: 23095120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of medium-chain acyl-CoA dehydrogenase deficiency G-985 mutation in sudden infant death syndrome.
    Miller ME; Brooks JG; Forbes N; Insel R
    Pediatr Res; 1992 Apr; 31(4 Pt 1):305-7. PubMed ID: 1570195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening.
    Smon A; Groselj U; Debeljak M; Zerjav Tansek M; Bertok S; Avbelj Stefanija M; Trebusak Podkrajsek K; Battelino T; Repic Lampret B
    J Int Med Res; 2018 Apr; 46(4):1339-1348. PubMed ID: 29350094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of MCAD deficiency in Japan: 16years' experience of enzymatic and genetic evaluation.
    Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Hata I; Shigematsu Y; Kobayashi M
    Mol Genet Metab; 2016 Dec; 119(4):322-328. PubMed ID: 27856190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.
    Chace DH; DiPerna JC; Mitchell BL; Sgroi B; Hofman LF; Naylor EW
    Clin Chem; 2001; 47(7):1166-82. PubMed ID: 11427446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
    Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
    Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.
    Bentler K; Zhai S; Elsbecker SA; Arnold GL; Burton BK; Vockley J; Cameron CA; Hiner SJ; Edick MJ; Berry SA;
    Mol Genet Metab; 2016 Sep; 119(1-2):75-82. PubMed ID: 27477829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening.
    Leydiker KB; Neidich JA; Lorey F; Barr EM; Puckett RL; Lobo RM; Abdenur JE
    Mol Genet Metab; 2011 May; 103(1):92-5. PubMed ID: 21354840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation.
    Blois B; Riddell C; Dooley K; Dyack S
    J Inherit Metab Dis; 2005; 28(4):551-6. PubMed ID: 15902558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.